/* SLIDE GALLERY FOR HOME PAGE */ /* SLIDE GALLERY FOR ABOUT CARDICA */


Cardiac Surgery

Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System, for coronary artery bypass graft (CABG) surgery and has shipped over 50,000 units throughout the world. The proprietary stapling technology underlying Cardica‚Äôs automated anastomosis systems is designed to minimize operating time and enable robot-assisted surgeries.

During CABG procedures, a surgeon takes a small part of a blood vessel from another part of the body and attaches it across an area of severe narrowing or blockage, "bypassing" the portion of the artery that is impairing blood flow to the heart muscle. The connection of this vessel, the anastomosis, is often considered the most critical aspect of the procedure.

We believe that by replacing hand-sewn sutures with automated systems, our C-Port and PAS-Port Systems allow cardiovascular surgeons to perform consistent, reliable anastomoses with even the smallest of vessels, ultimately improving patient outcomes. The C-Port systems are commercially available in the United States and Europe. The PAS-Port system has been used in Japan and Europe since 2004, receiving 510(k) clearance in the United States in 2008.


 



Dextera Surgical designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures.
> Read More
Dextera Surgicals stapling technology is designed to minimize operating time and to enable minimally-invasive and robot-assisted surgeries.
> Read More
Receive all the latest updates about Cardica
Share this website with your friends.